International Health News
Newsletter
Resources

My favourite Supplements

International Health News
Useful, authoritative and timely summaries
of the latest research in health, nutrition and medicine.

Index 2011-2016

ARCHIVES 2016

Bullet Issue 273....December 2016/January 2017....25th Year

EDITORIAL
THIS MONTH's TOPICS
Autism: An epidemic that is treatable
Does metformin really work?
Know your numbers
References


Subscription to IHN


Bullet Issue 272....November 2016....25th Year

EDITORIAL
THIS MONTH's TOPICS
How effective is blood pressure lowering therapy?
Sepsis. Always be on the alert
Salt restriction is not the answer for everyone
References


Subscription to IHN


Bullet Issue 271....October 2016....25th Year

EDITORIAL
THIS MONTH's TOPICS
A blood pressure paradox
Flu vaccine effectiveness
Overestimation of cardiovascular event rates
Active monitoring for localized prostate cancer
References


Subscription to IHN


Bullet Issue 270....September 2016....25th Year

EDITORIAL
THIS MONTH's TOPICS
The toxic world, children and neurodevelopment
Modifiable risk factors for stroke. The INTERSTROKE Study
Cholesterol: The myth on steroids. Does it matter anymore?
References

Perspective and Research Review
Cancer and the role of Salvestrols
By William R. Ware, Ph.D.
  • Introduction
  • Cancer in perspective
  • What causes cancer?
  • After diagnosis, decisions, decisions, decisions
  • Salvestrols for cancer therapy
  • Other sets of case histories
  • Failures, interference and inhibition of Salvestrol action
  • Diagnosis by detecting CYP1B1 in serum
  • Monitoring the success of therapy with serum CYP1B1 metabolites
  • Salvestrols for primary prevention of cancer?
  • Doses
  • The future?
  • Conclusions
  • Recommended additional reading
  • References

Subscription to IHN


Bullet Issue 269....July/August 2016....25th Year

EDITORIAL
THIS MONTH's TOPICS
New study of the Newcastle diet for type 2 diabetes
Cholesterol. Is lower better?
Strong evidence that cardiovascular risks are vastly overstated
Aspirin for primary prevention of cardiovascular disease and stroke
Iron overload and liver cancer and non-alcoholic fatty liver disease
References

Research Review
The risk of too much iron.
Serum ferritin levels viewed as normal may present significant health issues
By William R. Ware, Ph.D.
  • Introduction
  • Ferritin levels and reference ranges regarded as normal
  • Association and thresholds of ferritin levels and the risk of various diseases
  • Ferritin thresholds for benefit in iron-lowering studies
  • Iron stores reduction and diabetic complications
  • Iron reduction and non-alcoholic fatty liver disease
  • Iron and oxidative DNA damage
  • What is the optimum ferritin level?
  • Influence of blood donation or phlebotomy on ferritin levels
  • Chelation, the alternative to phlebotomy or blood donation
  • Conclusions
  • References

Subscription to IHN


Bullet Issue 268....June 2016....25th Year

EDITORIAL
THIS MONTH's TOPICS
Medium chain triglycerides for declining memory
Ketone ester for type 3 diabetes and Alzheimer'd disease
False hope from the HOPE-3 study
Dealing with the major factors affecting longevity

References

Subscription to IHN


Bullet Issue 267....May 2016....25th Year

EDITORIAL
THIS MONTH's TOPICS
Psychiatrist Peter Breggin throws down the gauntlet once again
J'accuse! Giving psychiatric drugs to children is child abuse
Attention-Deficit Hyperactivity Disorder (ADHD)
Bipolar disorder
Antipsychiatry debate and pro-side defence
Psychiatric myths
If one rejects psychiatric drugs what does one do?

Bibliography
References

Subscription to IHN


Bullet Issue 266....April 2016....25th Year

EDITORIAL
THIS MONTH's TOPICS
Polyunsaturated fat 101
Does a vegetarian diet lead to lower all-cause mortality and cancer risk?
Does alcohol increase the risk of diabetes?
Salt restriction. How compelling is the evidence?
Mysterious 20th century epidemic of heart disease

References

Subscription to IHN


Bullet Issue 265....March 2016....25th Year

EDITORIAL
THIS MONTH's TOPICS
Prevention of cancer - one of the biggest challenges we face
Why do so many individuals have zero coronary artery calcification?
The saga of Paxil and the notorious study 329 casts a shadow over clinical trials
Very low blood pressure targets. Major or minor benefit?
Books - Fictional therapy

References

Subscription to IHN


Bullet Issue 264....February 2016....25th Year

EDITORIAL
THIS MONTH's TOPICS
Are cardiovascular disease assessments flawed?
Major risk factors for pancreatic cancer
The dangers of fructose consumption
Bariatric surgery reverses type 2 diabetes
Proton pump inhibitors and kidney disease
References

Perspective and Commentary
Cardiovascular Risk Assessment and Over-Diagnosis
By William R. Ware, Ph.D.
  • Introduction
  • Assessing risk and establishing guidelines
  • Problems and issues with the new guideline
  • What we can learn from the MESA risk calculator
  • Cholesterol and coronary calcium (atherosclerosis)
  • Coronary calcium score - The ignored key to cardiovascular assessment
  • Conclusions
  • References

Subscription to IHN


My favourite Supplements

Home Page
Editor
Vitamin Shop
Archives

2016 copyright notice